Clinical Trial Update: Methylphenidate for Ptsd and Stroke Veterans [Phase 1, Phase 2]

View source ↗

Summary

The VA conducted a Phase 1/2 trial of methylphenidate in veterans with PTSD and stroke, and results were posted in June 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder
• Stroke

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: VA Office of Research and Development | Conditions: PTSD, Stroke | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-06-22